Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

Clinical trial NCT00106808 · COMPLETED

Trial details

NCT number: NCT00106808
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2005-08-01
Primary completion: 2006-08-01
Enrollment: 1440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.